A prediction model for differentiating recurrent Kawasaki disease from other febrile illnesses

Kawasaki disease (KD) can result in coronary artery aneurysms (CAA), elevating the risk of coronary artery thrombosis in the later stage [1]. Intravenous immunoglobulin within the first 10 days after fever onset is the primary therapy for KD, which greatly reduces the incidence of CAA [1].